Abstract
The improvement of technique, materials, and chemotherapy regimens have significantly increased the role of endovascular therapy in tumor management. Preoperative embolization of tumors with polyvinyl alcohol (PVA) particles is both safe and beneficial in reducing intraoperative blood loss and operating time. While there are other embolic agents available, including liquid embolisates and detachable coils, they are primarily used for specific situations. Newer agents such as embospheres and cellulose beads may have a larger role in the future due to being more uniform in size than PVA particles, but evidence to support this is lacking.
Provocative testing with Wada testing prior to embolization has a limited role as there is a high false-negative rate. Balloon test occlusions can provide useful information when vessel sacrifice is being considered for tumor management.
Preoperative embolization of hyper-vascular tumors such as meningiomas and juvenile nasopharyngiomas has less morbidity than surgery alone. Complications of embolization primarily involve dangerous anastomoses. Avoiding embolizations that are high risk and understanding how to minimize these risks are key in keeping morbidity low. Carotid blowout is a life-threatening complication of tumors of the neck and is managed utilizing endovascular technique, either via constructive or deconstructive methods.
Intra-arterial (IA) chemotherapy has recently begun to show promise in both primary and metastatic disease as both a primary modality and adjunct to standard therapy. Utilizing cerebral hemispheric dose calculations and appropriate catheter positioning and technique has reduced neurotoxicity as well as increasing local chemotherapy doses delivered IA when compared to conventional intravenous chemotherapy.
The blood–brain barrier presents unique challenges in treating tumors of the central nervous system. There has been an increasing use of IA osmotic blood–brain barrier disruption with IA chemotherapy with little evidence to support its benefit. Other mechanisms of blood–brain barrier disruption are under investigation.
Advances in retinoblastoma over the past 10 years have made IA melphalan with or without carboplatin a safe procedure with significant globe sparing and reduction in retinal seeding. Early results of IA bevacizumab in gliomas are promising, showing tumor size reduction and suggesting a role for vascular endothelial growth factor (VEGF) inhibitors in hyper-vascular tumors. There is an increasing role of intra-arterial Abraxane and platin containing compounds in the management of neck carcinomas with good success. The future of IA chemotherapy is promising as selective targeting of tumors based on angiogenesis and other tumor-specific features becomes more feasible.
Abbreviations
- Balloon test occlusion:
-
is when a vessel is temporarily occluded to assess collateral blood supply. This is typically done when there is the possibility that the vessel in question will be occluded and blood supply to organs distal to the occlusion is desired. If there is insufficient flow to the organ from other vessels, it is considered a failed test.
- Blood–brain barrier:
-
is a physiological barrier which regulates the passage of molecules from the blood to the central nervous system.
- Blood–brain barrier or blood–tumor barrier disruption:
-
is the act of disrupting the natural barriers which exist between the blood vessels and the brain or tumor. This is usually done for the purpose of enhancing drug delivery to the tumor as these barriers shield them from foreign substances.
- Blood–tumor barrier:
-
is a physiological barrier which regulated the passage of molecules from the blood to the tumor parenchyma.
- Carotid blowout syndrome:
-
is a massive hemorrhage from the common carotid artery or its branches. This is secondary to trauma or invasion of the carotid artery by infiltrative tumors with subsequent weakening and rupture of the vessel wall.
- Embolic agents:
-
are materials introduced into a vessel for the purpose of occlusion of the blood supply of a tumor.
- Endovascular therapy:
-
is a form of minimally invasive surgery designed to access many regions of the body via major blood vessels. Basic techniques involve the introduction of a catheter percutaneously into a large blood vessel, typically the femoral artery. The catheter is then guided to the region of interest.
- Endovascular tumor embolization:
-
is the method by which the vascular supply of a tumor is reduced or removed using embolic agent by the endovascular therapy route.
- Intra-arterial chemotherapy:
-
is the delivery of chemotherapeutic drugs to a tumor by releasing them locally into the feeding arteries of the tumor.
- Parent vessel occlusion:
-
is the destructive embolization of an artery that feeds a specific territory (or parent) such as a hemisphere of the brain or tumor.
- Posterior reversible encephalopathy syndrome:
-
is a syndrome characterized by headache, confusion, seizures, and visual loss.
- Provocative testing:
-
is a test conducted to assess the risk of neurological sequela if intra-arterial embolization or parent vessel sacrifice were to be performed from the catheter site where the test is performed. This is performed using medications that temporarily prevent neuronal depolarization with amobarbital and/or lidocaine. It is occasionally utilized before endovascular embolization or surgical resection.
- Spatial dose fractionation:
-
is a method of calculating the dose of chemotherapeutic drug to be delivered to specific arterial territories of the brain. It limits the dose for toxicity based on the maximum tolerable dose injected into each hemispheric blood circulation.
- Streaming:
-
is when the chemotherapeutic drug flows into nontarget vessels during infusion due to slow or continuous infusion. This produces a more asymmetric dose delivered to the arteries being infused, thereby reducing predictability of the infusion and potentially reducing the dose delivered to the tumor and increasing the chemotherapeutic drug dose to healthy parenchyma.
- Vascular endothelial growth factor:
-
is a signal protein produced by cells that stimulates vasculogenesis and angiogenesis.
- AChor:
-
Anterior choroidal
- ACNU:
-
Nimustine (1-(4-amino-2-methyl-5-pyrimidinyl)-methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride)
- AMA:
-
Accessory meningeal artery
- AP:
-
Anterior posterior
- APA:
-
Ascending pharyngeal artery
- ASA:
-
Anterior spinal arteries
- BBB:
-
Blood–brain barrier
- BBBD:
-
Blood–brain barrier disruption
- BCNU:
-
Bis-chloroethylnitrosourea also known as carmustine
- BTB:
-
Blood–tumor barrier
- BTB:
-
Blood–tumor barrier
- BTO:
-
Balloon test occlusion
- CBS:
-
Carotid blowout syndrome
- CCA:
-
Common carotid artery
- CNS:
-
Central nervous system
- CT:
-
Computed tomography
- DMSO:
-
Dimethyl sulfoxide
- ECA:
-
External carotid artery
- EEG:
-
Electroencephalogram
- EVOH:
-
Ethylene vinyl alcohol copolymer
- GABA:
-
Gamma-aminobutyric acid
- IA:
-
Intra-arterial
- ICA:
-
Internal carotid artery
- IMA:
-
Internal maxillary artery
- IV:
-
Intravenous
- JNA:
-
Juvenile nasopharyngeal angiofibroma
- LS:
-
Lenticulostriate
- MCA:
-
Middle cerebral artery
- MMA:
-
Middle meningeal artery
- MRI:
-
Magnetic resonance imaging
- MRI:
-
Magnetic resonance imaging
- NBCA:
-
N-butyl cyanoacrylate
- PCA:
-
Posterior cerebral artery
- PComm:
-
Posterior communicating
- PMA:
-
Posterior meningeal artery
- PRES:
-
Posterior reversible encephalopathy syndrome
- PSA:
-
Posterior spinal arteries
- PVA:
-
Polyvinyl alcohol
- RADPLAT:
-
Radiotherapy and concomitant intra-arterial cisplatin (RADPLAT)
- SPARC:
-
Secreted protein acidic and rich in cysteine
- STA:
-
Superficial temporal artery
- TAGM:
-
Tris-acryl gelatin microspheres
- VA:
-
Vertebral artery
- VEGF:
-
Vascular endothelial growth factor
- VHL:
-
von Hippel–Lindau
References
Abi 007 (2003) Drugs R D, 4(5) 303–305
Abo-Al Hassan A, Ismail M, Panda SM (2006) Pre-operative endovascular embolization of a cerebellar haemangioblastoma. A case report. Med Princ Pract 15(6):459–462. doi:10.1159/000095495
Abramson DH (2011) Chemosurgery for retinoblastoma: what we know after 5 years. Arch Ophthalmol 129(11):1492–1494. doi:10.1001/archophthalmol.2011.354
Abramson DH, Schefler AC (2004) Update on retinoblastoma. Retina 24:828–848
Abramson DH, Dunkel IJ, Brodie SE, Kim JW, Gobin YP (2008a) A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results. Ophthalmology 115:1398–1404. doi: S0161-6420(07) 01359-0 [pii], 10.1016/j.ophtha.2007.12.014
Abramson DH, Dunkel IJ, Brodie SE, Kim JW, Gobin YP (2008b) A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results. Ophthalmology 115(8):1398–1404. doi:10.1016/j.ophtha.2007.12.014, 1404 e1391
Abramson DH, Dunkel IJ, Brodie SE, Marr B, Gobin YP (2010) Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery). Ophthalmology 117:1623–1629
Abramson DH, Marr BP, Brodie SE, Dunkel I, Palioura S, Gobin YP (2012a) Ophthalmic artery chemosurgery for less advanced intraocular retinoblastoma: five year review. PLoS One 7(4):e34120. doi:10.1371/journal.pone.0034120
Abramson DH, Marr BP, Brodie SE, Dunkel IJ, Palioura S, Gobin YP (2012b) Ophthalmic artery chemosurgery for less advanced intraocular retinoblastoma: five year review. doi: 10.1371/journal.pone.0034120
Abramson DH, Marr BP, Dunkel IJ, Brodie SE, Zabor EC, Driscoll SJ, Gobin YP (2012c) Intra-arterial chemotherapy for retinoblastoma in eyes with vitreous and/or subretinal seeding: 2-year results. Br J Ophthalmol 96:499–502. doi:10.1136/bjophthalmol-2011-300498
Abud DG, Mounayer C, Benndorf G, Piotin M, Spelle L, Moret J (2004) Intratumoral injection of cyanoacrylate glue in head and neck paragangliomas. AJNR Am J Neuroradiol 25(9):1457–1462
Adler JR, Upton J, Wallman J, Winston KR (1986) Management and prevention of necrosis of the scalp after embolization and surgery for meningioma. Surg Neurol 25(4):357–360
Akai H, Kiryu S, Takao H, Tajima T, Shibahara J, Imamura H, Ohtomo K (2009) Efficacy of double-arterial phase gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced liver magnetic resonance imaging compared with double-arterial phase multi-detector row helical computed tomography. J Comput Assist Tomogr 33(6):887–892. doi:10.1097/RCT.0b013e3181a1ca7e
Altenbernd J, Heusner TA, Ringelstein A, Ladd SC, Forsting M, Antoch G (2011) Dual-energy-CT of hypervascular liver lesions in patients with HCC: investigation of image quality and sensitivity. Eur Radiol 21(4):738–743. doi:10.1007/s00330-010-1964-7
American Society of I, Therapeutic N (2001) Head, neck, and brain tumor embolization. AJNR Am J Neuroradiol 22(8 Suppl):S14–S15
Aoki S, Terada H, Kosuda S, Shitara N, Fujii H, Suzuki K et al (1993) Supraophthalmic chemotherapy with long tapered catheter: distribution evaluated with intraarterial and intravenous Tc-99m HMPAO. Radiology 188(2):347–350
Aschenbach R, Basche S, Esser D, Vogl TJ (2012) Usefulness of ultrafast dynamic 3D-T1w data acquisition in detection of hypervascular lesions of the middle ear: first experience. Eur J Radiol 81(2):257–261. doi:10.1016/j.ejrad.2010.11.011
Bargellini I, Florio F, Golfieri R, Grosso M, Lauretti DL, Cioni R (2013) Trends in utilization of transarterial treatments for hepatocellular carcinoma: results of a survey by the Italian society of interventional radiology. Cardiovasc Intervent Radiol. doi:10.1007/s00270-013-0656-5
Barnes LTL, Hunt JL, Michaels L (2005) Tumours of the paraganglionic system: introduction. In: Barnes L, Eveson J, Reichart P, Sidransky D (eds) World health organization classification of tumours: pathology and genetics of head and neck tumours. IARC Press, Lyon, p 362
Barr JD, Lemley TJ, McCann RM (1998) Carotid artery balloon test occlusion: combined clinical evaluation and xenon-enhanced computed tomographic cerebral blood flow evaluation without patient transfer or balloon reinflation: technical note. Neurosurgery 43(3):634–637; discussion 637–638
Barrett T, Brechbiel M, Bernardo M, Choyke PL (2007) MRI of tumor angiogenesis. J Magn Reson Imaging 26(2):235–249. doi:10.1002/jmri.20991
Batsakis JG, Klopp CT, Newman W (1955) Fibrosarcoma arising in a juvenile nasopharyngeal angiofibroma following extensive radiation therapy. Am Surg 21(8):786–793
Beltramello A, Benati A, Perini S, Maschio A (1989) Interventional angiography in neuropediatrics. Childs Nerv Syst 5(2):87–93
Bendszus M, Klein R, Burger R, Warmuth-Metz M, Hofmann E, Solymosi L (2000a) Efficacy of trisacryl gelatin microspheres versus polyvinyl alcohol particles in the preoperative embolization of meningiomas. AJNR Am J Neuroradiol 21(2):255–261
Bendszus M, Rao G, Burger R, Schaller C, Scheinemann K, Warmuth-Metz M, Solymosi L (2000b) Is there a benefit of preoperative meningioma embolization? Neurosurgery 47(6):1306–1311; discussion 1311–1302
Bendszus M, Martin-Schrader I, Schlake HP, Solymosi L (2003) Embolisation of intracranial meningiomas without subsequent surgery. Neuroradiology 45(7):451–455. doi:10.1007/s00234-003-1005-1
Bendszus M, Monoranu CM, Schutz A, Nolte I, Vince GH, Solymosi L (2005) Neurologic complications after particle embolization of intracranial meningiomas. AJNR Am J Neuroradiol 26(6):1413–1419
Berkefeld J, Scale D, Kirchner J, Heinrich T, Kollath J (1999) Hypervascular spinal tumors: influence of the embolization technique on perioperative hemorrhage. AJNR Am J Neuroradiol 20(5):757–763
Bertino G, Occhini A, Falco CE, Porta C, Corbella F, Colombo S, Benazzo M (2009) Concurrent intra-arterial carboplatin administration and radiation therapy for the treatment of advanced head and neck squamous cell carcinoma: short term results. BMC Cancer 9:313. doi:10.1186/1471-2407-9-313
Bianciotto C, Shields CL, Iturralde JC, Sarici A, Jabbour P, Shields JA (2012) Fluorescein angiographic findings after intra-arterial chemotherapy for retinoblastoma. Ophthalmology 119(4):843–849. doi:10.1016/j.ophtha.2011.09.040
Blacklock JB, Wright DC, Dedrick RL, Blasberg RG, Lutz RJ, Doppman JL, Oldfield EH (1986) Drug streaming during intra-arterial chemotherapy. J Neurosurg 64(2):284–291. doi:10.3171/jns.1986.64.2.0284
Boockvar JA, Tsiouris AJ, Hofstetter CP, Kovanlikaya I, Fralin S, Kesavabhotla K, Riina HA (2011) Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood–brain barrier disruption for recurrent malignant glioma. Clinical article. J Neurosurg 114(3):624–632. doi:10.3171/2010.9.JNS101223
Brodie SE, Gobin YP, Dunkel IJ, Kim JW, Abramson DH (2009) Persistence of retinal function after selective ophthalmic artery chemotherapy infusion for retinoblastoma. Doc Ophthalmol 119:13–22. doi:10.1007/s10633-008-9164-3
Brodsky SV, Mendelev N, Melamed M, Ramaswamy G (2007) Vascular density and VEGF expression in hepatic lesions. J Gastrointestin Liver Dis 16(4):373–377
Burkhardt JK, Shin BJ, Schlaff CD, Riina H, Boockvar JA (2011) Cost analysis of intra-arterial versus intra-venous delivery of bevacizumab for the treatment of recurrent glioblastoma multiforme. J Exp Ther Oncol 9(3):183–186
Carli DF, Sluzewski M, Beute GN, van Rooij WJ (2010) Complications of particle embolization of meningiomas: frequency, risk factors, and outcome. AJNR Am J Neuroradiol 31(1):152–154. doi:10.3174/ajnr.A1754
Casasco A, Herbreteau D, Houdart E, George B, Tran Ba Huy P, Deffresne D, Merland JJ (1994) Devascularization of craniofacial tumors by percutaneous tumor puncture. AJNR Am J Neuroradiol 15(7):1233–1239
Casasco A, Houdart E, Biondi A, Jhaveri HS, Herbreteau D, Aymard A, Merland JJ (1999) Major complications of percutaneous embolization of skull-base tumors. AJNR Am J Neuroradiol 20(1):179–181
Chaloupka JC, Putman CM, Citardi MJ, Ross DA, Sasaki CT (1996) Endovascular therapy for the carotid blowout syndrome in head and neck surgical patients: diagnostic and managerial considerations. AJNR Am J Neuroradiol 17(5):843–852
Chaloupka JC, Mangla S, Huddle DC, Roth TC, Mitra S, Ross DA, Sasaki CT (1999) Evolving experience with direct puncture therapeutic embolization for adjunctive and palliative management of head and neck hypervascular neoplasms. Laryngoscope 109(11):1864–1872. doi:10.1097/00005537-199911000-00028
Chan RC, Thompson GB (1984) Ischemic necrosis of the scalp after preoperative embolization of meningeal tumors. Neurosurgery 15(1):76–81
Chang FC, Luo CB, Lirng JF, Guo WY, Wu HM, Teng MM, Chang CY (2008) Complications of carotid blowout syndrome in patients with head and neck cancers treated by covered stents. Interv Neuroradiol 14(Suppl 2):29–33
Chao Y, Li CP, Chau GY, Chen CP, King KL, Lui WY, Lee SD (2003) Prognostic significance of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin in patients with resectable hepatocellular carcinoma after surgery. Ann Surg Oncol 10(4):355–362
Chlenski A, Cohn SL (2010) Modulation of matrix remodeling by SPARC in neoplastic progression. Semin Cell Dev Biol 21(1):55–65. doi:10.1016/j.semcdb.2009.11.018
Choi S, Han JW, Kim H, Kim BS, Kim DJ, Lee SC, Lyu CJ (2013) Combined chemotherapy and intra-arterial chemotherapy of retinoblastoma. Korean J Pediatr 56(6):254–259. doi:10.3345/kjp.2013.56.6.254
Choyke PL, Dwyer AJ, Knopp MV (2003) Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging 17(5):509–520. doi:10.1002/jmri.10304
Christensen NP, Smith DS, Barnwell SL, Wax MK (2005) Arterial embolization in the management of posterior epistaxis. Otolaryngol Head Neck Surg 133(5):748–753. doi:10.1016/j.otohns.2005.07.041
Chun JY, McDermott MW, Lamborn KR, Wilson CB, Higashida R, Berger MS (2002) Delayed surgical resection reduces intraoperative blood loss for embolized meningiomas. Neurosurgery 50(6):1231–1235, discussion 1235–1237
Chung J, Yu JS, Kim DJ, Chung JJ, Kim JH, Kim KW (2011) Hypervascular hepatocellular carcinoma in the cirrhotic liver: diffusion-weighted imaging versus superparamagnetic iron oxide-enhanced MRI. Magn Reson Imaging 29(9):1235–1243. doi:10.1016/j.mri.2011.07.025
Citardi MJ, Chaloupka JC, Son YH, Ariyan S, Sasaki CT (1995) Management of carotid artery rupture by monitored endovascular therapeutic occlusion (1988–1994). Laryngoscope 105(10):1086–1092. doi:10.1288/00005537-199510000-00015
Cloughesy TF, Gobin YP, Black KL, Vinuela F, Taft F, Kadkhoda B, Kabbinavar F (1997) Intra-arterial carboplatin chemotherapy for brain tumors: a dose escalation study based on cerebral blood flow. J Neurooncol 35(2):121–131
Collins JM (1984) Pharmacologic rationale for regional drug delivery. J Clin Oncol 2(5):498–504
Correll JT, Wise EC (1945) Certain properties of a new physiologically absorbable sponge. Proc Soc Exp Biol Med 58(3):233–235
Damascelli B, Patelli GL, Lanocita R, Di Tolla G, Frigerio LF, Marchiano A, Cantu G (2003) A novel intraarterial chemotherapy using paclitaxel in albumin nanoparticles to treat advanced squamous cell carcinoma of the tongue: preliminary findings. AJR Am J Roentgenol 181(1):253–260. doi:10.2214/ajr.181.1.1810253
Damascelli B, Patelli G, Ticha V, Di Tolla G, Frigerio LF, Garbagnati F, Zunino F (2007) Feasibility and efficacy of percutaneous transcatheter intraarterial chemotherapy with paclitaxel in albumin nanoparticles for advanced squamous-cell carcinoma of the oral cavity, oropharynx, and hypopharynx. J Vasc Interv Radiol 18(11):1395–1403. doi:10.1016/j.jvir.2007.06.009
Dare AO, Chaloupka JC, Putman CM, Fayad PB, Awad IA (1998) Failure of the hypotensive provocative test during temporary balloon test occlusion of the internal carotid artery to predict delayed hemodynamic ischemia after therapeutic carotid occlusion. Surg Neurol 50(2):147–155; discussion 155–146
Dawbarn RM (1904) The starvation operation for malignancy in the external carotid area. Its failures and successes. JAMA XLIII(12):792–795. doi:10.1001/jama.1904.92500120002g
de Bazelaire C, Calmon R, Chapellier M, Pluvinage A, Frija J, de Kerviler E (2010) CT and MRI imaging in tumoral angiogenesis. Bull Cancer 97(1):79–90. doi:10.1684/bdc.2010.0961
Dean BL, Flom RA, Wallace RC, Khayata MH, Obuchowski NA, Hodak JA, Spetzler RF (1994) Efficacy of endovascular treatment of meningiomas: evaluation with matched samples. AJNR Am J Neuroradiol 15(9):1675–1680
DeLellis RA (2004) Pathology & genetics: tumours of endocrine organs. IARC 8:165
Desai N, Trieu V, Damascelli B, Soon-Shiong P (2009) SPARC expression correlates with tumor response to albumin-bound paclitaxel in head and neck cancer patients. Transl Oncol 2(2):59–64
Deshmukh VR, Fiorella DJ, McDougall CG, Spetzler RF, Albuquerque FC (2005) Preoperative embolization of central nervous system tumors. Neurosurg Clin N Am 16(2):411–432. doi:10.1016/j.nec.2004.08.010, xi
Deveikis JP (1996) Sequential injections of amobarbital sodium and lidocaine for provocative neurologic testing in the external carotid circulation. AJNR Am J Neuroradiol 17(6):1143–1147
Djindjian R, Cophignon J, Theron J, Merland JJ, Houdart R (1973) Embolization by superselective arteriography from the femoral route in neuroradiology. Review of 60 cases. 1. Technique, indications, complications. Neuroradiology 6(1):20–26
Doolittle ND, Petrillo A, Bell S, Cummings P, Eriksen S (1998) Blood–brain barrier disruption for the treatment of malignant brain tumors: the national program. J Neurosci Nurs 30(2):81–90
Doolittle ND, Miner ME, Hall WA, Siegal T, Jerome E, Osztie E, Neuwelt EA (2000) Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood–brain barrier for the treatment of patients with malignant brain tumors. Cancer 88(3):637–647
Doweck I, Robbins KT, Vieira F (2001) Analysis of risk factors predictive of distant failure after targeted chemoradiation for advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 127(11):1315–1318
Dropcho EJ (2001) Novel chemotherapeutic approaches to brain tumors. Hematol Oncol Clin North Am 15(6):1027–1052
Duffis EJ, Gandhi CD, Prestigiacomo CJ, Abruzzo T, Albuquerque F, Bulsara KR, Society for Neurointerventional Surgery (2012) Head, neck, and brain tumor embolization guidelines. J Neurointerv Surg 4(4):251–255. doi:10.1136/neurintsurg-2012-010350
Eagle RC Jr, Shields CL, Bianciotto C, Jabbour P, Shields JA (2011) Histopathologic observations after intra-arterial chemotherapy for retinoblastoma. Arch Ophthalmol 129(11):1416–1421. doi:10.1001/archophthalmol.2011.223
Eller JL, Hopkins LN (2013) Use of vascular plug devices in the management of neurovascular emergencies. World Neurosurg. doi:10.1016/j.wneu.2013.09.031
Ellis JA, D’Amico R, Sisti MB, Bruce JN, McKhann GM, Lavine SD, Strozyk D (2011) Pre-operative intracranial meningioma embolization. Expert Rev Neurother 11(4):545–556. doi:10.1586/ern.11.29
Eminowicz GK, Raman R, Conibear J, Plowman PN (2012) Bevacizumab treatment for vestibular schwannomas in neurofibromatosis type two: report of two cases, including responses after prior gamma knife and vascular endothelial growth factor inhibition therapy. J Laryngol Otol 126(1):79–82. doi:10.1017/S0022215111002805
English GM, Hemenway WG, Cundy RL (1972) Surgical treatment of invasive angiofibroma. Arch Otolaryngol 96(4):312–318
Ensminger WD, Gyves JW (1983) Regional chemotherapy of neoplastic diseases. Pharmacol Ther 21(2):277–293
Erickson D, Kudva YC, Ebersold MJ, Thompson GB, Grant CS, van Heerden JA, Young WF Jr (2001) Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients. J Clin Endocrinol Metab 86(11):5210–5216
Eskridge JM, McAuliffe W, Harris B, Kim DK, Scott J, Winn HR (1996) Preoperative endovascular embolization of craniospinal hemangioblastomas. AJNR Am J Neuroradiol 17(3):525–531
Fields JN, Halverson KJ, Devineni VR, Simpson JR, Perez CA (1990) Juvenile nasopharyngeal angiofibroma: efficacy of radiation therapy. Radiology 176(1):263–265
Finn RS, Zhu AX (2009) Targeting angiogenesis in hepatocellular carcinoma: focus on VEGF and bevacizumab. Expert Rev Anticancer Ther 9(4):503–509. doi:10.1586/era.09.6
Francis JH, Gobin YP, Brodie SE, Marr BP, Dunkel IJ, Abramson DH (2012) Experience of intra-arterial chemosurgery with single agent carboplatin for retinoblastoma. Br J Ophthalmol 96:1270–1271. doi:10.1136/bjophthalmol-2012-301686
Francis JH, Gobin YP, Dunkel IJ, Marr BP, Brodie SE, Jonna G, Abramson DH (2013) Carboplatin +/− topotecan ophthalmic artery chemosurgery for intraocular retinoblastoma. PLoS One. doi:10.1371/journal.pone.0072441
Fu S, Naing A, Moulder SL, Culotta KS, Madoff DC, Ng CS, Kurzrock R (2011) Phase I trial of hepatic arterial infusion of nanoparticle albumin-bound paclitaxel: toxicity, pharmacokinetics, and activity. Mol Cancer Ther 10(7):1300–1307. doi:10.1158/1535-7163.MCT-11-0259
Garcia-Cervigon E, Bien S, Rufenacht D, Thurel C, Reizine D, Tran Ba Huy P, Merland JJ (1988) Pre-operative embolization of naso-pharyngeal angiofibromas. Report of 58 cases. Neuroradiology 30(6):556–560
Gelman M, Chakeres DW, Newton HB (1999) Brain tumors: complications of cerebral angiography accompanied by intraarterial chemotherapy. Radiology 213(1):135–140
Gemmete JJ, Ansari SA, McHugh J, Gandhi D (2009) Embolization of vascular tumors of the head and neck. Neuroimaging Clin N Am 19(2):181–198. doi:10.1016/j.nic.2009.01.008, Table of Contents
George B, Casasco A, Deffrennes D, Houdart E (1994) Intratumoral embolization of intracranial and extracranial tumors: technical note. Neurosurgery 35(4):771–773; discussion 773–774
Geyik S, Cil BE, Yavuz K, Peynircioglu B, Saatci I, Cekirge S (2008) Neuroapplication of amplatzer vascular plug: a novel device for parent artery occlusion. Neuroradiology 50(2):179–183. doi:10.1007/s00234-007-0307-0
Gobin YP, Cloughesy TF, Chow KL, Duckwiler GR, Sayre JW, Milanese K, Vinuela F (2001a) Intraarterial chemotherapy for brain tumors by using a spatial dose fractionation algorithm and pulsatile delivery. Radiology 218(3):724–732
Gobin YP, Murayama Y, Milanese K, Chow K, Gonzalez NR, Duckwiler GR, Vinuela F (2001b) Head and neck hypervascular lesions: embolization with ethylene vinyl alcohol copolymer–laboratory evaluation in Swine and clinical evaluation in humans. Radiology 221(2):309–317
Gobin Y, Dunkel I, Marr B, Brodie S, Abramson D (2011a) Intra-arterial chemotherapy for the management of retinoblastoma. Four-year experience. Arch Ophthalmol 129:732–737
Gobin YP, Dunkel IJ, Marr BP, Brodie SE, Abramson DH (2011b) Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience. Arch Ophthalmol 129(6):732–737. doi:10.1001/archophthalmol.2011.5
Gobin YP, Dunkel IJ, Marr BP, Francis J, Brodie SE, Abramson D (2012) Combined, sequential intravenous and intra-arterial chemotherapy (bridge chemotherapy) for young infants with retinoblastoma. PLoS One 7(9):e44322. doi:10.1371/journal.pone.0044322
Gradishar WJ (2006) Albumin-bound paclitaxel: a next-generation taxane. Expert Opin Pharmacother 7(8):1041–1053. doi:10.1517/14656566.7.8.1041
Gralla J, Schroth G, Kickuth R, El-Koussy M, Do DD, Brekenfeld C (2008) Closing the gap between coil and balloon in the neurointerventional armamentarium? Initial clinical experience with a nitinol vascular occlusion plug. Neuroradiology 50(8):709–714. doi:10.1007/s00234-008-0396-4
Groothuis DR (2000) The blood–brain and blood-tumor barriers: a review of strategies for increasing drug delivery. Neuro Oncol 2(1):45–59
Gruber A, Killer M, Mazal P, Bavinzski G, Richling B (2000) Preoperative embolization of intracranial meningiomas: a 17-years single center experience. Minim Invasive Neurosurg 43(1):18–29. doi:10.1055/s-2000-8812
Grunstein J, Masbad JJ, Hickey R, Giordano F, Johnson RS (2000) Isoforms of vascular endothelial growth factor act in a coordinate fashion to recruit and expand tumor vasculature. Mol Cell Biol 20(19):7282–7291
Gullane PJ, Davidson J, O’Dwyer T, Forte V (1992) Juvenile angiofibroma: a review of the literature and a case series report. Laryngoscope 102(8):928–933. doi:10.1288/00005537-199208000-00014
Gupta R, Thomas AJ, Horowitz M (2006a) Intracranial head and neck tumors: endovascular considerations, present and future. Neurosurgery 59(5 Suppl 3):S251–S260. doi:10.1227/01.NEU.0000239249.65742.1C; discussion S253-213
Gupta S, Kobayashi S, Phongkitkarun S, Broemeling LD, Kan Z (2006b) Effect of transcatheter hepatic arterial embolization on angiogenesis in an animal model. Invest Radiol 41(6):516–521. doi:10.1097/01.rli.0000209663.00629.8a
Hamada J, Kai Y, Nagahiro S, Hashimoto N, Iwata H, Ushio Y (1996a) Embolization with cellulose porous beads, II: clinical trial. AJNR Am J Neuroradiol 17(10):1901–1906
Hamada J, Ushio Y, Kazekawa K, Tsukahara T, Hashimoto N, Iwata H (1996b) Embolization with cellulose porous beads, I: an experimental study. AJNR Am J Neuroradiol 17(10):1895–1899
Hamza SM, Kaufman S (2004) A vibrator prevents streaming during close-arterial infusion into the kidney. Am J Physiol Renal Physiol 286(4):F643–F646. doi:10.1152/ajprenal.00290.2003
Happold C, Roth P, Wick W, Steinbach JP, Linnebank M, Weller M, Eisele G (2009) ACNU-based chemotherapy for recurrent glioma in the temozolomide era. J Neurooncol 92(1):45–48. doi:10.1007/s11060-008-9728-9
Hekster RE, Matricali B, Luyendijk W (1974) Presurgical transfemoral catheter embolization to reduce operative blood loss. Technical note. J Neurosurg 41(3):396–398. doi:10.3171/jns.1974.41.3.0396
Herkes GK, Morgan M, Grinnell V, Sorby W, Wong J, Rowe D, Stroud J (1993) EEG monitoring during angiographic balloon test carotid occlusion: experience in sixteen cases. Clin Exp Neurol 30:98–103
Hilal SK, Michelsen JW (1975) Therapeutic percutaneous embolization for extra-axial vascular lesions of the head, neck, and spine. J Neurosurg 43(3):275–287. doi:10.3171/jns.1975.43.3.0275
Hodozuka A, Sako K, Nakai H, Tomabechi M, Suzuki N, Yonemasu Y (1993) Delivery of a novel nitrosourea, MCNU, to the brain tissue in glioma-bearing rats. Intracarotid versus intravenous infusion. J Neurooncol 15(1):79–86
Horton JA, Kerber CW (1986) Lidocaine injection into external carotid branches: provocative test to preserve cranial nerve function in therapeutic embolization. AJNR Am J Neuroradiol 7(1):105–108
Horton JA, Marano GD, Kerber CW, Jenkins JJ, Davis S (1983) Polyvinyl alcohol foam-Gelfoam for therapeutic embolization: a synergistic mixture. AJNR Am J Neuroradiol 4(2):143–147
Horton JA, Eelkema E, Albright AL (1989) Preoperative embolization of a hemangioblastoma. AJNR Am J Neuroradiol 10(1):203
Houston SK, Lampidis TJ, Murray TG (2013) Models and discovery strategies for new therapies of retinoblastoma. Expert Opin Drug Discov 8(4):383–394. doi:10.1517/17460441.2013.772975
Ikeda N, Adachi M, Taki T, Huang C, Hashida H, Takabayashi A, Miyake M (1999) Prognostic significance of angiogenesis in human pancreatic cancer. Br J Cancer 79(9–10):1553–1563. doi:10.1038/sj.bjc.6690248
Imbesi F, Marchioni E, Benericetti E, Zappoli F, Galli A, Corato M, Ceroni M (2006) A randomized phase III study: comparison between intravenous and intraarterial ACNU administration in newly diagnosed primary glioblastomas. Anticancer Res 26(1B):553–558
Jabbour P, Chalouhi N, Tjoumakaris S, Gonzalez LF, Dumont AS, Chitale R, Shields C (2012) Pearls and pitfalls of intraarterial chemotherapy for retinoblastoma. J Neurosurg Pediatr 10(3):175–181. doi:10.3171/2012.5.PEDS1277
Jagannathan J, Lonser RR, Smith R, DeVroom HL, Oldfield EH (2008) Surgical management of cerebellar hemangioblastomas in patients with von Hippel-Lindau disease. J Neurosurg 108(2):210–222. doi:10.3171/JNS/2008/108/2/0210
Jindal G, Gemmete J, Gandhi D (2012) Interventional neuroradiology applications in otolaryngology, head and neck surgery. Otolaryngol Clin North Am 45(6):1423–1449. doi:10.1016/j.otc.2012.08.010
Kai Y, Hamada JI, Morioka M, Yano S, Nakamura H, Makino K, Kuratsu JI (2006) Clinical evaluation of cellulose porous beads for the therapeutic embolization of meningiomas. AJNR Am J Neuroradiol 27(5):1146–1150
Kai Y, Hamada J, Morioka M, Yano S, Nakamura H, Makino K, Kuratsu J (2007) Preoperative cellulose porous beads for therapeutic embolization of meningioma: provocation test and technical considerations. Neuroradiology 49(5):437–443. doi:10.1007/s00234-007-0218-0
Kallmes DF, Evans AJ, Kaptain GJ, Mathis JM, Jensen ME, Jane JA, Dion JE (1997) Hemorrhagic complications in embolization of a meningioma: case report and review of the literature. Neuroradiology 39(12):877–880
Kanematsu M, Kondo H, Goshima S, Kato H, Tsuge U, Hirose Y, Moriyama N (2006) Imaging liver metastases: review and update. Eur J Radiol 58(2):217–228. doi:10.1016/j.ejrad.2005.11.041
Kanno H, Yamamoto I, Nishikawa R, Matsutani M, Wakabayashi T, Yoshida J, Clinical VH L. R. G. i. J (2009) Spinal cord hemangioblastomas in von Hippel-Lindau disease. Spinal Cord 47(6):447–452. doi:10.1038/sc.2008.151
Kim LJ, Albuquerque FC, Aziz-Sultan A, Spetzler RF, McDougall CG (2006) Low morbidity associated with use of n-butyl cyanoacrylate liquid adhesive for preoperative transarterial embolization of central nervous system tumors. Neurosurgery 59(1):98–104. doi:10.1227/01.NEU.0000220215.71485.07; discussion 198–104
Klufas MA, Gobin YP, Marr B, Brodie SE, Dunkel IJ, Abramson DH (2012a) Intra-arterial chemotherapy as a treatment for intraocular retinoblastoma: alternatives to direct ophthalmic artery catheterization. AJNR Am J Neuroradiol 33(8):1608–1614. doi:10.3174/ajnr.A3019
Klufas MA, Gobin YP, Marr BP, Brodie SE, Dunkel IJ, Abramson DH (2012b) Intra-arterial chemotherapy as a treatment for intraocular retinoblastoma: alternatives to direct ophthalmic artery catheterization. AJNR 33:1608–1614
Kochi M, Ushio Y (2002) Chemo-radiotherapy for malignant brain tumors. Gan To Kagaku Ryoho 29(5):669–676
Kretzschmar K, Milewski C, Dienes HP (1988) The risk of endocrine activation in interventional procedures on paraganglioma of the head and neck. Radiologe 28(11):497–502
Kumagai T, Takeda N, Fukase S, Koshu H, Inoue A, Ibuchi Y, Yoneoka Y (2003) Intra-arterial chemotherapy for malignant tumors of head and neck region using three types of modified injection method. Interv Neuroradiol 9(Suppl 1):113–123
Kuroiwa T, Tanaka H, Ohta T, Tsutsumi A (1996) Preoperative embolization of highly vascular brain tumors: clinical and histopathological findings. Noshuyo Byori 13(1):27–36
Lallana EC, Abrey LE (2003) Update on the therapeutic approaches to brain tumors. Expert Rev Anticancer Ther 3(5):655–670. doi:10.1586/14737140.3.5.655
Lambert CR, Leone JE, Rowland SM (1993) Local drug delivery catheters: functional comparison of porous and microporous designs. Coron Artery Dis 4(5):469–475
Latchaw RE, Gold LH (1979) Polyvinyl foam embolization of vascular and neoplastic lesions of the head, neck, and spine. Radiology 131(3):669–679
Lavertu P, Bonafede JP, Adelstein DJ, Saxton JP, Strome M, Wanamaker JR, Wood BG (1998) Comparison of surgical complications after organ-preservation therapy in patients with stage III or IV squamous cell head and neck cancer. Arch Otolaryngol Head Neck Surg 124(4):401–406
Lefkowitz M, Giannotta SL, Hieshima G, Higashida R, Halbach V, Dowd C, Teitelbaum GP (1998) Embolization of neurosurgical lesions involving the ophthalmic artery. Neurosurgery 43(6):1298–1303
Lehane DE, Bryan RN, Horowitz B, DeSantos L, Ehni G, Zubler MA et al (1983) Intraarterial cis-platinum chemotherapy for patients with primary and metastatic brain tumors. Cancer Drug Deliv 1(1):69–77
Levin MH, Gombos DS, O’Brien JM (2011) Intra-arterial chemotherapy for advanced retinoblastoma: is the time right for a prospective clinical trial? Arch Ophthalmol 129(11):1487–1489. doi:10.1001/archophthalmol.2011.304
Lewandowski RJ, Kulik LM, Riaz A, Senthilnathan S, Mulcahy MF, Ryu RK, Salem R (2009) A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization. Am J Transplant 9(8):1920–1928. doi:10.1111/j.1600-6143.2009.02695.x
Light RU, Prentice HR (1945) Surgical investigation of a new absorbable sponge derived from gelatin for use in hemostasis. J Neurosurg 2(5):435–455. doi:DOI 10.3171/jns.1945.2.5.0435
Linskey ME, Jungreis CA, Yonas H, Hirsch WL Jr, Sekhar LN, Horton JA, Janosky JE (1994) Stroke risk after abrupt internal carotid artery sacrifice: accuracy of preoperative assessment with balloon test occlusion and stable xenon-enhanced CT. AJNR Am J Neuroradiol 15(5):829–843
Liu QL, Wang YF, Mao GS, Yang XJ, Sun YF, Miao LX, Zhao F (2012) Analysis on the safety of ophthalmic artery cannulation for intra-arterial chemotherapy in 42 patients with intraocular stage retinoblastoma. Zhonghua Er Ke Za Zhi 50(10):793–797
Loffroy R, Guiu B, Cercueil JP, Krause D (2009) Endovascular therapeutic embolisation: an overview of occluding agents and their effects on embolised tissues. Curr Vasc Pharmacol 7(2):250–263
Lowis GW, Minagar A (2003) The neglected research of Egas Moniz of internal carotid artery (ICA) occlusion. J Hist Neurosci 12(3):286–291. doi:10.1076/jhin.12.3.286.16677
Luessenhop AJ, Gibbs M, Velasquez AC (1962) Cerebrovascular response to emboli. Observations in patients with arteriovenous malformations. Arch Neurol 7:264–274
Lutz RJ, Miller DL (1988) Mixing studies during hepatic artery infusion in an in vitro model. Cancer 62(6):1066–1073
Lutz RJ, Dedrick RL, Boretos JW, Oldfield EH, Blacklock JB, Doppman JL (1986) Mixing studies during intracarotid artery infusions in an in vitro model. J Neurosurg 64(2):277–283. doi:10.3171/jns.1986.64.2.0277
Lutz RJ, Epstein AH, Cook JA, Dedrick RL (1995) An in vitro flow model to study streaming during pelvic intra-arterial drug infusions. Gynecol Oncol 59(2):288–296. doi:10.1006/gyno.1995.0024
Lutz RJ, Warren K, Balis F, Patronas N, Dedrick RL (2002) Mixing during intravertebral arterial infusions in an in vitro model. J Neurooncol 58(2):95–106
Macpherson P (1991) The value of pre-operative embolisation of meningioma estimated subjectively and objectively. Neuroradiology 33(4):334–337
Manelfe C, Lasjaunias P, Ruscalleda J (1986) Preoperative embolization of intracranial meningiomas. AJNR Am J Neuroradiol 7(5):963–972
Mangini M, Lagana D, Fontana F, Ianniello A, Nicotera P, Petulla M, Fugazzola C (2008) Use of Amplatzer Vascular Plug (AVP) in emergency embolisation: preliminary experience and review of literature. Emerg Radiol 15(3):153–160. doi:10.1007/s10140-007-0696-8
Manke C, Bretschneider T, Lenhart M, Strotzer M, Neumann C, Gmeinwieser J, Feuerbach S (2001) Spinal metastases from renal cell carcinoma: effect of preoperative particle embolization on intraoperative blood loss. AJNR Am J Neuroradiol 22(5):997–1003
Manning SC, Culbertson MC (2002) Epistaxis. In: C. M. Bluestone CD, Stool SE et al. (eds) Pediatric Otolaryngology, 4th edn. Saunders, Philadelphia, p 925
Maran AG, Amin M, Wilson JA (1989) Radical neck dissection: a 19-year experience. J Laryngol Otol 103(8):760–764
Marr BP, Brodie SE, Dunkel IJ, Gobin YP, Abramson DH (2012) Three-drug intra-arterial chemotherapy using simultaneous carboplatin, topotecan and melphalan for intraocular retinoblastoma: preliminary results. Br J Ophthalmol 96(10):1300–1303. doi:10.1136/bjophthalmol-2012-301925
Martin AJ, Cha S, Higashida RT, Cullen SP, Halbach V, Dowd CF, Saloner DA (2007) Assessment of vasculature of meningiomas and the effects of embolization with intra-arterial MR perfusion imaging: a feasibility study. AJNR Am J Neuroradiol 28(9):1771–1777. doi:10.3174/ajnr.A0647
Matsumoto Y, Freund KB, Peiretti E, Cooney MJ, Ferrara DC, Yannuzzi LA (2007) Rebound macular edema following bevacizumab (Avastin) therapy for retinal venous occlusive disease. Retina 27(4):426–431. doi:10.1097/IAE.0b013e31804a7af2
Meyer PN, Fu K, Greiner T, Smith L, Delabie J, Gascoyne R, Weisenburger DD (2011) The stromal cell marker SPARC predicts for survival in patients with diffuse large B-cell lymphoma treated with rituximab. Am J Clin Pathol 135(1):54–61. doi:10.1309/AJCPJX4BJV9NLQHY
Miyagami M, Tsubokawa T (1990) Chemotherapy with ACNU and radiation therapy in malignant glioma in cerebral hemisphere of adult. Gan To Kagaku Ryoho 17(8 Pt 1):1447–1453
Moniz E (1927) L’ence´ phalographie arte´rielle son importance dans la localisation des tumeurs ce´re´brales. Rev Neurol (Paris) 2:72–90
Morgan JE, Breau RL, Suen JY, Hanna EY (2007) Surgical wound complications after intensive chemoradiotherapy for advanced squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 133(1):10–14. doi:10.1001/archotol.133.1.10
Morris P (1999) Interventional neuroradiology in the treatment of brain tumors. Neuroimaging Clin N Am 9(4):767–778
Moulin G, Chagnaud C, Gras R, Gueguen E, Dessi P, Gaubert JY, Cannoni M (1995) Juvenile nasopharyngeal angiofibroma: comparison of blood loss during removal in embolized group versus nonembolized group. Cardiovasc Intervent Radiol 18(3):158–161
Mulcahy MF, Lewandowski RJ, Ibrahim SM, Sato KT, Ryu RK, Atassi B, Salem R (2009) Radioembolization of colorectal hepatic metastases using yttrium-90 microspheres. Cancer 115(9):1849–1858. doi:10.1002/cncr.24224
Nadel FHF (2006) In: Fleisher GR, Henretig FM (eds) Textbook of pediatric emergency medicine, 5th edn. Lippincott Williams & Wilkins, Philadelphia, Epistaxis. p 263
Nagulic M, Nagulic I, Vujnic V (1989) Implantation of radioactive isotopes in intracranial tumors. Acta Chir Iugosl 36(2):203–218
Nakagawa H, Miyawaki Y, Tokiyoshi K, Tsuruzono K, Yamada M, Kanayama T, Hayakawa T (1994) Pharmacokinetics of plasma and cerebrospinal fluid cisplatin in patients with malignant glioma and metastatic brain tumor after selective intraarterial or intravenous and intracarotid administration of etoposide and cisplatin. No Shinkei Geka 22(1):35–42
Narita Y (2013) Drug review: safety and efficacy of bevacizumab for glioblastoma and other brain tumors. Jpn J Clin Oncol 43(6):587–595. doi:10.1093/jjco/hyt051
Neel HB 3rd, Whicker JH, Devine KD, Weiland LH (1973) Juvenile angiofibroma. Review of 120 cases. Am J Surg 126(4):547–556
Neumann HP, Eggert HR, Weigel K, Friedburg H, Wiestler OD, Schollmeyer P (1989) Hemangioblastomas of the central nervous system. A 10-year study with special reference to von Hippel-Lindau syndrome. J Neurosurg 70(1):24–30. doi:10.3171/jns.1989.70.1.0024
Neuwelt EA, Maravilla KR, Frenkel EP, Rapaport SI, Hill SA, Barnett PA (1979) Osmotic blood–brain barrier disruption. Computerized tomographic monitoring of chemotherapeutic agent delivery. J Clin Invest 64(2):684–688. doi:10.1172/JCI109509
Newman JP, Terris DJ, Pinto HA, Fee WE Jr, Goode RL, Goffinet DR (1997) Surgical morbidity of neck dissection after chemoradiotherapy in advanced head and neck cancer. Ann Otol Rhinol Laryngol 106(2):117–122
Newton HB (2005) Intra-arterial chemotherapy of primary brain tumors. Curr Treat Options Oncol 6(6):519–530
Numa Y, Kasai H, Imahori T, Tsuchida T, Kawamoto K (1994) Effective measures against side effects by increasing ACNU dose for malignant glioma: effects on digestive organs. Gan To Kagaku Ryoho 21(12):2029–2033
Ong CK, Lam DV, Ong MT, Power MA, Parkinson RJ, Wenderoth JD (2009) Neuroapplication of amplatzer vascular plug for therapeutic sacrifice of major craniocerebral arteries: an initial clinical experience. Ann Acad Med Singapore 38(9):763–768
Palioura S, Gobin YP, Brodie SE, Marr BP, Dunkel IJ, Abramson DH (2012) Ophthalmic artery chemosurgery for the management of retinoblastoma in eyes with extensive (>50 %) retinal detachment. Pediatr Blood Cancer 59:859–864. doi:10.1002/pbc.24170
Parker F, Aghakhani N, Ducati LG, Yacubian-Fernandes A, Silva MV, David P, Tadie M (2009) Results of microsurgical treatment of medulla oblongata and spinal cord hemangioblastomas: a comparison of two distinct clinical patient groups. J Neurooncol 93(1):133–137. doi:10.1007/s11060-009-9861-0
Patsalides A, Fraser JF, Smith MJ, Kraus D, Gobin YP, Riina HA (2010) Endovascular treatment of carotid blowout syndrome: who and how to treat. J Neurointerv Surg 2(1):87–93. doi:10.1136/jnis.2009.001131
Pauw BK, Makek MS, Fisch U, Valavanis A (1993) Preoperative embolization of paragangliomas (glomus tumors) of the head and neck: histopathologic and clinical features. Skull Base Surg 3(1):37–44
Persky MS, Setton A, Niimi Y, Hartman J, Frank D, Berenstein A (2002) Combined endovascular and surgical treatment of head and neck paragangliomas–a team approach. Head Neck 24(5):423–431. doi:10.1002/hed.10068
Plotkin SR, Merker VL, Halpin C, Jennings D, McKenna MJ, Harris GJ, Barker FG 2nd (2012) Bevacizumab for progressive vestibular schwannoma in neurofibromatosis type 2: a retrospective review of 31 patients. Otol Neurotol 33(6):1046–1052. doi:10.1097/MAO.0b013e31825e73f5
Pollak JS, White RI Jr (2001) The use of cyanoacrylate adhesives in peripheral embolization. J Vasc Interv Radiol 12(8):907–913
Prabhu VC, Bilsky MH, Jambhekar K, Panageas KS, Boland PJ, Lis E, Nelson PK (2003) Results of preoperative embolization for metastatic spinal neoplasms. J Neurosurg Spine 98(2):156–164
Quadros RS, Gallas S, Delcourt C, Dehoux E, Scherperel B, Pierot L (2006) Preoperative embolization of a cervicodorsal paraganglioma by direct percutaneous injection of onyx and endovascular delivery of particles. AJNR Am J Neuroradiol 27(9):1907–1909
Qureshi AI (2004) Endovascular treatment of cerebrovascular diseases and intracranial neoplasms. Lancet 363(9411):804–813. doi:10.1016/S0140-6736(04)15697-3
Rafi S, Piduru SM, El-Rayes B, Kauh JS, Kooby DA, Sarmiento JM, Kim HS (2013) Yttrium-90 radioembolization for unresectable standard-chemorefractory intrahepatic cholangiocarcinoma: survival, efficacy, and safety study. Cardiovasc Intervent Radiol 36(2):440–448. doi:10.1007/s00270-012-0463-4
Rapoport SI, Hori M, Klatzo I (1971) Reversible osmotic opening of the blood–brain barrier. Science 173(4001):1026–1028
Rauch RA, Vinuela F, Dion J, Duckwiler G, Amos EC, Jordan SE, Bentson J (1992) Preembolization functional evaluation in brain arteriovenous malformations: the ability of superselective Amytal test to predict neurologic dysfunction before embolization. AJNR Am J Neuroradiol 13(1):309–314
Ribeiro N, Sousa SR, Brekken RA, Monteiro FJ (2013) Role of SPARC in bone remodeling and cancer-related bone metastasis. J Cell Biochem. doi:10.1002/jcb.24649
Richter HP, Schachenmayr W (1983) Preoperative embolization of intracranial meningiomas. Neurosurgery 13(3):261–268
Ricke J, Grosser O, Amthauer H (2013) Y90-Radioembolization of lung metastases via the bronchial artery: a report of 2 cases. Cardiovasc Intervent Radiol. doi:10.1007/s00270-013-0690-3
Riina HA, Fraser JF, Fralin S, Knopman J, Scheff RJ, Boockvar JA (2009) Superselective intraarterial cerebral infusion of bevacizumab: a revival of interventional neuro-oncology for malignant glioma. J Exp Ther Oncol 8(2):145–150
Rodiek SO, Stolzle A, Lumenta CB (2004) Preoperative embolization of intracranial meningiomas with embosphere microspheres. Minim Invasive Neurosurg 47(5):299–305. doi:10.1055/s-2004-830069
Rosen CL, Ammerman JM, Sekhar LN, Bank WO (2002) Outcome analysis of preoperative embolization in cranial base surgery. Acta Neurochir (Wien) 144(11):1157–1164. doi:10.1007/s00701-002-0965-y
Rossitti S (2007) Preoperative embolization of lower-falx meningiomas with ethylene vinyl alcohol copolymer: technical and anatomical aspects. Acta Radiol 48(3):321–326. doi:10.1080/02841850601161547
Sadato A, Taki W, Nakahara I, Nishi S, Yamashita K, Matsumoto K, Kikuchi H (1994) Improved provocative test for the embolization of arteriovenous malformations–technical note. Neurol Med Chir (Tokyo) 34(3):187–190
Sakashita T, Homma A, Oridate N, Hatakeyama H, Kano S, Mizumachi T, Fukuda S (2012) Evaluation of nodal response after intra-arterial chemoradiation for node-positive head and neck cancer. Eur Arch Otorhinolaryngol 269(6):1671–1676. doi:10.1007/s00405-011-1814-5
Salem R, Lewandowski RJ, Mulcahy MF, Riaz A, Ryu RK, Ibrahim S, Kulik L (2010) Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes. Gastroenterology 138(1):52–64. doi:10.1053/j.gastro.2009.09.006
Saris SC, Wright DC, Oldfield EH, Blasberg RG (1988) Intravascular streaming and variable delivery to brain following carotid artery infusions in the Sprague–Dawley rat. J Cereb Blood Flow Metab 8(1):116–120. doi:10.1038/jcbfm.1988.15
Saris SC, Blasberg RG, Carson RE, deVroom HL, Lutz R, Dedrick RL et al (1991) Intravascular streaming during carotid artery infusions. Demonstration in humans and reduction using diastole-phased pulsatile administration. J Neurosurg 74(5):763–772. doi:10.3171/jns.1991.74.5.0763
Sassler AM, Esclamado RM, Wolf GT (1995) Surgery after organ preservation therapy. Analysis of wound complications. Arch Otolaryngol Head Neck Surg 121(2):162–165
Schinkel AH (1999) P-Glycoprotein, a gatekeeper in the blood–brain barrier. Adv Drug Deliv Rev 36(2–3):179–194
Schinkel AH (2001) The roles of P-glycoprotein and MRP1 in the blood–brain and blood-cerebrospinal fluid barriers. Adv Exp Med Biol 500:365–372
Schinkel AH, Smit JJ, van Tellingen O, Beijnen JH, Wagenaar E, van Deemter L et al (1994) Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood–brain barrier and to increased sensitivity to drugs. Cell 77(4):491–502
Schinkel AH, Wagenaar E, Mol CA, van Deemter L (1996) P-glycoprotein in the blood–brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. J Clin Invest 97(11):2517–2524. doi:10.1172/JCI118699
Schirmer CM, Hoit DA, Malek AM (2008) Amplatzer-onyx sandwich: a method for impermeable proximal cerebral vessel occlusion. J Vasc Interv Radiol 19(3):459–460. doi:10.1016/j.jvir.2007.11.017
Sekhar LN, Biswas A, Hallam D, Kim LJ, Douglas J, Ghodke B (2009) Neuroendovascular management of tumors and vascular malformations of the head and neck. Neurosurg Clin N Am 20(4):453–485. doi:10.1016/j.nec.2009.07.007
Shankar JJ, Maloney WJ, Vandorpe R (2011) Amplatzer vascular plug for occlusion of parent artery in carotid blowout with active extravasation. Interv Neuroradiol 17(2):224–227
Shi ZS, Feng L, Jiang XB, Huang Q, Yang Z, Huang ZS (2008) Therapeutic embolization of meningiomas with Onyx for delayed surgical resection. Surg Neurol 70(5):478–481. doi:10.1016/j.surneu.2007.05.031
Shields CL, Ramasubramanian A, Rosenwasser R, Shields JA (2009) Superselective catheterization of the ophthalmic artery for intraarterial chemotherapy for retinoblastoma. Retina 29(8):1207–1209. doi:10.1097/IAE.0b013e3181b4ce39
Shields CL, Bianciotto CG, Jabbour P, Griffin GC, Ramasubramanian A, Rosenwasser R, Shields JA (2011a) Intra-arterial chemotherapy for retinoblastoma: report no. 2, treatment complications. Arch Ophthalmol 129(11):1407–1415. doi:10.1001/archophthalmol.2011.151
Shields CL, Bianciotto CG, Jabbour P, Ramasubramanian A, Lally SE, Griffin GC, Shields JA (2011b) Intra-arterial chemotherapy for retinoblastoma: report no. 1, control of retinal tumors, subretinal seeds, and vitreous seeds. Arch Ophthalmol 129(11):1399–1406. doi:10.1001/archophthalmol.2011.150
Shields CL, Kaliki S, Shah SU, Bianciotto CG, Liu D, Jabbour P, Shields JA (2012) Minimal exposure (one or two cycles) of intra-arterial chemotherapy in the management of retinoblastoma. Ophthalmology 119(1):188–192. doi:10.1016/j.ophtha.2011.06.036
Shields CL, Fulco EM, Arias JD, Alarcon C, Pellegrini M, Rishi P, Shields JA (2013a) Retinoblastoma frontiers with intravenous, intra-arterial, periocular, and intravitreal chemotherapy. Eye (Lond) 27(2):253–264. doi:10.1038/eye.2012.175
Shields CL, Kaliki S, Al-Dahmash S, Rojanaporn D, Leahey A, Griffin G, Shields JA (2013b) Management of advanced retinoblastoma with intravenous chemotherapy then intra-arterial chemotherapy as alternative to enucleation. Retina. doi:10.1097/IAE.0b013e318295f783
Shih T, Lindley C (2006) Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies. Clin Ther 28(11):1779–1802. doi:10.1016/j.clinthera.2006.11.015
Shook DR, Beaudet LM, Doppman JL (1987) Uniformity of intracarotid drug distribution with diastole-phased pulsed infusion. J Neurosurg 67(5):726–731. doi:10.3171/jns.1987.67.5.0726
Siegal T, Zylber-Katz E (2002) Strategies for increasing drug delivery to the brain: focus on brain lymphoma. Clin Pharmacokinet 41(3):171–186
Silva AC, Evans JM, McCullough AE, Jatoi MA, Vargas HE, Hara AK (2009) MR imaging of hypervascular liver masses: a review of current techniques. Radiographics 29(2):385–402. doi:10.1148/rg.292085123
Silvani A, Eoli M, Salmaggi A, Erbetta A, Fariselli L, Boiardi A (2002) Intra-arterial ACNU and carboplatin versus intravenous chemotherapy with cisplatin and BCNU in newly diagnosed patients with glioblastoma. Neurol Sci 23(5):219–224. doi:10.1007/s100720200044
Sonoda Y, Matsumoto K, Kakuto Y, Nishino Y, Kumabe T, Tominaga T, Katakura R (2007) Primary CNS lymphoma treated with combined intra-arterial ACNU and radiotherapy. Acta Neurochir (Wien) 149(11):1183–1189. doi:10.1007/s00701-007-1277-z; discussion 1189
Sorteberg A, Bakke SJ, Boysen M, Sorteberg W (2008) Angiographic balloon test occlusion and therapeutic sacrifice of major arteries to the brain. Neurosurgery 63(4):651–660. doi:10.1227/01.NEU.0000325727.51405.D5; discussion 660–651
Speakman TJ (1964) Internal occlusion of a carotid-cavernous fistula. J Neurosurg 21:303–305. doi:10.3171/jns.1964.21.4.0303
Stewart DJ (1989) Pros and cons of intra-arterial chemotherapy. Oncology (Williston Park) 3(10):20–26; discussion 26–27, 30, 32
Stewart DJ, Grahovac Z, Benoit B, Addison D, Richard MT, Dennery J et al (1984) Intracarotid chemotherapy with a combination of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), cis-diaminedichloroplatinum (cisplatin), and 4’-O-demethyl-1-O-(4,6-O-2-thenylidene-beta-D-glucopyranosyl) epipodophyllotoxin (VM-26) in the treatment of primary and metastatic brain tumors. Neurosurgery 15(6):828–833
Stewart DJ, Mikhael NZ, Nair RC, Kacew S, Montpetit V, Nanji A, Howard K (1988) Platinum concentrations in human autopsy tumor samples. Am J Clin Oncol 11(2):152–158
Stewart DJ, Grahovac Z, Hugenholtz H, DaSilva V, Richard MT, Benoit B, Russell N (1993) Feasibility study of intraarterial vs intravenous cisplatin, BCNU, and teniposide combined with systemic cisplatin, teniposide, cytosine arabinoside, glycerol and mannitol in the treatment of primary and metastatic brain tumors. J Neurooncol 17(1):71–79
Suzuki S, Yamane T, Mohri M, Kaneko A (2011) Selective ophthalmic arterial injection therapy for intraocular retinoblastoma: the long-term prognosis. Ophthalmology 118(10):2081–2087. doi:10.1016/j.ophtha.2011.03.013
Tadavarthy SM, Knight L, Ovitt TW, Snyder C, Amplatz K (1974) Therapeutic transcatheter arterial embolization. Radiology 112(1):13–16
Tadavarthy SM, Moller JH, Amplatz K (1975) Polyvinyl alcohol (Ivalon)–a new embolic material. Am J Roentgenol Radium Ther Nucl Med 125(3):609–616
Takeuchi S, Tanaka R, Fujii Y, Abe H, Ito Y (2001) Surgical treatment of hemangioblastomas with presurgical endovascular embolization. Neurol Med Chir (Tokyo) 41(5):246–251; discussion 251–242
Taki W, Yonekawa Y, Iwata H, Uno A, Yamashita K, Amemiya H (1990) A new liquid material for embolization of arteriovenous malformations. AJNR Am J Neuroradiol 11(1):163–168
Tang SC, Lagas JS, Lankheet NA, Poller B, Hillebrand MJ, Rosing H, Schinkel AH (2012) Brain accumulation of sunitinib is restricted by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and can be enhanced by oral elacridar and sunitinib coadministration. Int J Cancer 130(1):223–233. doi:10.1002/ijc.26000
Teasdale E, Patterson J, McLellan D, Macpherson P (1984) Subselective preoperative embolization for meningiomas. A radiological and pathological assessment. J Neurosurg 60(3):506–511. doi:10.3171/jns.1984.60.3.0506
Terada T, Nakamura Y, Tsuura M, Miyamoto K, Nakai K, Nishiguchi T, Komai N (1992) MRI changes in embolized meningiomas. Neuroradiology 34(2):162–167
Tfayli A, Hentschel P, Madajewicz S, Manzione J, Chowhan N, Davis R, Shady M (1999) Toxicities related to intraarterial infusion of cisplatin and etoposide in patients with brain tumors. J Neurooncol 42(1):73–77
Tikkakoski T, Luotonen J, Leinonen S, Siniluoto T, Heikkila O, Paivansalo M, Hyrynkangas K (1997) Preoperative embolization in the management of neck paragangliomas. Laryngoscope 107(6):821–826
Tomashefski JF Jr, Cohen AM, Doershuk CF (1988) Longterm histopathologic follow-up of bronchial arteries after therapeutic embolization with polyvinyl alcohol (Ivalon) in patients with cystic fibrosis. Hum Pathol 19(5):555–561
Tsimberidou AM, Ye Y, Wheler J, Naing A, Hong D, Nwosu U, Wolff RA (2013) A phase I study of hepatic arterial infusion of nab-paclitaxel in combination with intravenous gemcitabine and bevacizumab for patients with advanced cancers and predominant liver metastases. Cancer Chemother Pharmacol 71(4):955–963. doi:10.1007/s00280-013-2088-y
Vaidya S, Tozer KR, Chen J (2008) An overview of embolic agents. Semin Intervent Radiol 25(3):204–215. doi:10.1055/s-0028-1085930
Volk LD, Flister MJ, Chihade D, Desai N, Trieu V, Ran S (2011) Synergy of nab-paclitaxel and bevacizumab in eradicating large orthotopic breast tumors and preexisting metastases. Neoplasia 13(4):327–338
Wakabayashi T, Yoshida J, Mizuno M, Kajita Y (2001) Intratumoral microinfusion of nimustine (ACNU) for recurrent glioma. Brain Tumor Pathol 18(1):23–28
Wan WS, Lai V, Lau HY, Wong YC, Poon WL, Tan CB (2013) Endovascular treatment paradigm of carotid blowout syndrome: review of 8-years experience. Eur J Radiol 82(1):95–99. doi:10.1016/j.ejrad.2011.01.061
Wang AY, Chen CC, Lai HY, Lee ST (2013) Balloon test occlusion of the internal carotid artery with stump pressure ratio and venous phase delay technique. J Stroke Cerebrovasc Dis. doi:10.1016/j.jstrokecerebrovasdis.2013.05.036
Welander J, Soderkvist P, Gimm O (2011) Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas. Endocr Relat Cancer 18(6):R253–R276. doi:10.1530/ERC-11-0170
Wiemels J, Wrensch M, Claus EB (2010) Epidemiology and etiology of meningioma. J Neurooncol 99(3):307–314. doi:10.1007/s11060-010-0386-3
Wong HK, Lahdenranta J, Kamoun WS, Chan AW, McClatchey AI, Plotkin SR, di Tomaso E (2010) Anti-vascular endothelial growth factor therapies as a novel therapeutic approach to treating neurofibromatosis-related tumors. Cancer Res 70(9):3483–3493. doi:10.1158/0008-5472.CAN-09-3107
Wright JC (1984a) Cancer chemotherapy: past, present, and future–Part I. J Natl Med Assoc 76(8):773–784
Wright JC (1984b) Cancer chemotherapy: past, present, and future–Part II. J Natl Med Assoc 76(9):865–876
Yasuda S, Kondo M, Kachi S, Ito Y, Terui T, Ueno S, Terasaki H (2011) Rebound of macular edema after intravitreal bevacizumab therapy in eyes with macular edema secondary to branch retinal vein occlusion. Retina 31(6):1075–1082. doi:10.1097/IAE.0b013e318206cf4b
Zhang C, Mao Y, Leng B, Song DL, Zhou LF (2005) Application and reliability of balloon occlusion test in treatment of cerebrovascular diseases. Zhonghua Yi Xue Za Zhi 85(32):2243–2246
Zuniga RM, Torcuator R, Jain R, Anderson J, Doyle T, Schultz L, Mikkelsen T (2010) Rebound tumour progression after the cessation of bevacizumab therapy in patients with recurrent high-grade glioma. J Neurooncol 99(2):237–242. doi:10.1007/s11060-010-0121-0
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this entry
Cite this entry
Crimmins, M., Banihashemi, M.A., Gobin, Y.P., Knopman, J., Patsalides, A. (2014). Endovascular Management of Tumors of the Head, Neck, and Spine. In: Lanzer, P. (eds) PanVascular Medicine. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-37393-0_100-1
Download citation
DOI: https://doi.org/10.1007/978-3-642-37393-0_100-1
Received:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Online ISBN: 978-3-642-37393-0
eBook Packages: Springer Reference MedicineReference Module Medicine
Publish with us
Chapter history
-
Latest
Endovascular Management of Tumors of the Head, Neck, and Spine- Published:
- 20 February 2016
DOI: https://doi.org/10.1007/978-3-642-37393-0_100-2
-
Original
Endovascular Management of Tumors of the Head, Neck, and Spine- Published:
- 06 August 2014
DOI: https://doi.org/10.1007/978-3-642-37393-0_100-1